CLL Therapy: Focus on Comorbidities, Not Age

CHICAGO — The majority of patients with chronic lymphocytic leukemia are elderly patients older than 65, which underscores the need for a careful assessment of fitness for therapy — not necessarily because of age, but because of comorbidity burden, according to John G. Gribben, MD.

Source: Caring for the Ages - October 30, 2015 Category: Health Management Authors: Sharon Worcester Source Type: news